Abstract
An abnormal plasma polyunsaturated fatty acid pattern (PUFA) (increased n3 and decreased n6 PUFA) has been reported in active inflammatory bowel disease (IBD). The possibility of a primary defect in the PUFA metabolism in IBD was hypothesised. The On the basis of the above findings, it could be hypothesised that in the absence ofother factors, that is in inactive disease, the values oflong chain PUFA would be even higher. Therefore, the study of patients with inactive IBD would be of interest. In addition, to ascertain the possible existence of a primary defect in PUFA metabolism, the study of patients with ulcerative colitis who had had a colectomy would be particularly important, as in such patients, the target organ has been removed. The aim of this study was to assess prospectively the plasma fatty acid pattern in patients with inactive IBD (both ulcerative colitis and Crohn's disease), and in ulcerative colitis patients after colectomy. Arachidonic acid (C20:4n6), the main product of the n6 series, showed the same tendency. Statistical significance was only obtained, however, between the ulcerative colitis patients and controls, when the values were expressed as absolute plasma concentration. Absolute plasma values of linoleic acid (C18:2n6), the essential precursor of the n6 series, and ct-linolenic acid (C18:3n3), the essential precursor of the n3 series, were also increased in ulcerative colitis (Table II) .
Patients and methods

PATIENTS
As a consequence of the increase in long chain and highly unsaturated PUFA, the values of the 118 3 (7-0) 110 <0-00001tslI UNID were also significantly high, both in inactive ulcerative colitis and Crohn's disease, compared with controls (Table III) . Changes in saturated and monoenoic fatty acids depended on a diminished percentage of oleic acid (C18: 1n9) and an increased concentration of palmitic acid (C16:0) in ulcerative colitis with respect to the control group and an increased percentage of palmitoleic acid (C 16: 1) in Crohn's disease (Table III) .
After adjusting for age as described in the statistical methods section, the significance of the differences seen did not change. (Tables IV and V) Plasma docosahexaenoic acid (C22:6n3), either as a percentage or an absolute concentration, was significantly higher both in operated and nonoperated ulcerative colitis patients when compared with controls. In addition, when expressed as plasma concentration, C22:6n3 was significantly higher in non-operated than in operated patients (Table IV) . UNID was also significantly increased in both groups of patients compared with controls (Table V) .
In the n6 series, the plasma concentration of linoleic (C18:2n6) and arachidonic acid The increase in n6 long chain PUFA is particularly noticeable in non-active, non-operated ulcerative colitis patients, their values being significantly higher than those in healthy controls. Also, significantly increased values of the precursors of both n3 (C18:3n3) and n6 (C18:2n6) series were seen in this group of patients. As a high intake of essential fatty acids, particularly of a-linolenic acid (C18:3n3), was ruled out in all cases, this finding could be attributed to a negative feedback effect2'-23 upon 6-6 desaturase activity, caused by the excessive amount of products of both n3 (C22:6n3) and n6 series (C20:4n6). From these data, it could be speculated that the hypothesis of an increased PUFA biosynthesis is more active in ulcerative colitis than in Crohn's disease patients.
Differences in age distribution may account, at least in part, for the differences seen in plasma fatty acid concentrations between operated and non-operated patients and between ulcerative colitis patients and controls. After adjusting for age as a covariate, however, the significance of the results did not change, except for oleic acid concentration, which showed no differences between operated and non-operated ulcerative colitis patients.
Malnutrition may be another important factor that explains fatty acid differences among groups because PUFA deficiency has been described in malnourished patients.2425 Malnutrition only *occurred, however, in four (10%) ulcerative colitis and three (11%) Crohn's disease patients in this series. Moreover, vitamin and trace element deficiencies, which have been reported in active IBD,2627 could be additional factors influencing PUFA biosynthesis. Unfortunately, data on the micronutrient state in this series of non-active patients are not available.
A further argument in favour of the existence of an increased PUFA biosynthesis in IBD is the persistence of increased values of docosahexaenoic acid (C22:6n3) three to six months after colectomy in patients with ulcerative colitis. In addition, this finding suggests that it may be because of a primary metabolic defect. Although three to six months seems to be enough time to reach a stable state after colectomy, the possibility that plasma PUFA pattern took longer to return to normal has to be ruled out in future studies. Thus, a study comparing larger groups of patients with both proctocolectomy and colectomy plus ileal pouch patients, at least two years after the completion of surgery, has to be performed to confirm these results.
On the other hand, the hypothesis of a genetically determined primary defect in PUFA metabolism in IBD should be assessed by measuring PUFA profile in healthy relatives of IBD patients.
These results further support our reluctance to use long chain n3 PUFA in treatment for either acute attacks of IBD or for maintenance treatment of the disease.
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